Israeli real-world Pfizer vaccine study reports infection rates dropped by 33% in treatment group of 200K people >60 y.o vs 200K controls after 21 days, less than predicted by proponents of delaying 2nd dose. Stay on schedule until proven otherwise.

Medical Mythbusting Commentary for January 21, 2021


Quebec vaccine plan may be rethought after troubling Israeli data, says provincial advisor